Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study.
Nobuyasu AwanoTaisuke JoTakehiro IzumoMinoru InomataKojiro MoritaHiroki MatsuiKiyohide FushimiHirokazu UrushiyamaTakahide NagaseHideo YasunagaPublished in: Journal of intensive care (2022)
In patients with AE-IPF who developed severe respiratory failure, rTM in addition to high-dose mPSL was not associated with a better outcome.
Keyphrases
- respiratory failure
- idiopathic pulmonary fibrosis
- recombinant human
- high dose
- extracorporeal membrane oxygenation
- mechanical ventilation
- interstitial lung disease
- low dose
- stem cell transplantation
- early onset
- chronic obstructive pulmonary disease
- acute respiratory distress syndrome
- cross sectional
- drug induced
- rheumatoid arthritis
- hepatitis b virus